The Partnership Development Office establishes the partnerships and collaborations among Frederick National Laboratory scientists and external researchers in government, academia, industry, the nonprofit research sector, small/start-up businesses and entrepreneurs, as well as neighbors in our community.
Meet Our Team
As director of the Partnership Development Office (PDO), Vladimir Popov manages and oversees the partnerships and collaborations among Frederick National Laboratory scientists and external researchers in government, industry, academia, and the nonprofit research community. The PDO identifies strategic partnership opportunities capable of addressing important scientific questions and unmet medical needs, evaluates and manages the national laboratory’s intellectual property portfolio, and actively engages in marketing and licensing efforts. He works closely with the Intellectual Property and Strategic Agreements to negotiate strategic agreements with a diverse array of partners.
Popov brings extensive experience in business development, technology transfer, and project management. Before assuming the role of director, Popov served as a business development manager for the PDO. Previously, Popov worked as a manager in the healthcare industry, entrepreneur, and licensing manager. He completed two postdoctoral fellowships at Thomas Jefferson University and the University of Pennsylvania. He holds a Ph.D. in Biochemistry and Molecular Biology and a B.S. in Biochemistry from Thomas Jefferson University. Popov is currently pursuing his M.B.A. at Johns Hopkins University – Carey Business School.
Maggie Scully has been at the Frederick National Laboratory since 2016, and she champions relationships, particularly with academic partners, in line with FNL’s strategic goals. She previously worked on the Alliance Management team in the FNL’s Nanotechnology Characterization Laboratory (NCL), supporting collaborations between NCL and academic, corporate, and non-profit groups. Prior to joining the FNL, Scully was on the founding team of a biotech start-up company developing long-acting pharmaceuticals for cancer and rare disease indications. She earned her Ph.D. in Biomedical Engineering from Stony Brook University, while conducting nanomedicine research at NIH’s National Institute of Biomedical Imaging and Bioengineering. She then completed a postdoctoral research fellowship at Johns Hopkins Institute for NanoBioTechnology and later Johns Hopkins School of Medicine. Her experience in academia, NIH, and the start-up community had a lasting impact on her career trajectory, propelling her to venture further into the business development and technology transfer field.
Victoria Brun provides project management support across the PDO’s broad portfolio of collaborative projects. In particular, she manages the Technical Services Program, which provides external researchers access to unique services available exclusively at the Frederick National Laboratory, and the Laboratory-Directed Exploratory Research program, which provides FNL investigators with an opportunity to receive research funding awarded through a competitive review process. With a background in technical and science writing, she also handles communication and outreach activities for the PDO, in coordination with the Public Affairs and Communications group. She earned her B.S. from Towson University and her M.P.H. in Epidemiology from the University of Alabama at Birmingham.
As partnership alliance manager, Amanda Corbel provides program management and business development support within the PDO. More specifically, she manages the NCI Technology Transfer Center (TTC) Invention Development Program (IDP), which aims to accelerate the development timeline of NCI intramural inventions by advancing the technologies through critical, early stages of validation. In addition, she helps with establishing partnerships and collaborations among the national laboratory and the external research community.
She holds a B.S. in Biology from Shepherd University and a M.S. in Biotechnology and Business Management from Mount Saint Mary’s University. She is also a certified Project Management Professional through the Project Management Institute.
Saifur Rahman brings decade of industry drug discovery experience to the PDO. As part of his responsibilities at the Frederick National Laboratory, Rahman provides strategic insight to the establishment of standards and references initiative, which will enable sharing common agreed standardized technical methodologies as well as training opportunities with the external scientific community. Rahman earned his Ph.D. in Microbiology and Immunology from Drexel University with focus on dendritic cells in the context of retroviral immunology. Given his interest in translational research, he joined Pfizer for postdoctoral training. During his time at Pfizer, he worked on understanding the role of dendritic cells and T-cells in humanized mouse model of psoriasis and other similar IL-17 mediated autoimmune diseases. After completing his postdoctoral training, Rahman joined Medimmune (now AstraZeneca) in pre-clinical research. There he was part of a group that was involved in establishing a novel systems biology approach to drug discovery for a disease with severe unmet medical need—systemic lupus erythematosus. Later, he transitioned to a clinical group within AstraZeneca supporting late stage immuno-oncology assets. During his time at Pfizer and AstraZeneca, Rahman was also engaged with the organizational business development unit on various search and evaluation, competitive intelligence, and partnering projects. This exposure motivated him to complete his M.B.A. from University of Massachusetts Amherst.